Why Do Chinese Pharma IPOs Get Rejected? Financial Advisor Offers Tips
This article was originally published in PharmAsia News
Executive Summary
A university finance advisor attributes pharma companies’ IPO rejections to their weak internal management and inadequate project profitability.